Clinical Trials Directory

Trials / Completed

CompletedNCT04654871

Effects of Glucosamine and Chondroitin Sulfate Supplementation in Addition to Resistance Exercise Training and Manual Therapy in Patients With Knee Osteoarthritis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Foundation University Islamabad · Academic / Other
Sex
All
Age
40 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Osteoarthritis (OA) IS one of the most common joint disorders, affecting not only the joints but also the surrounding muscles, which become weak. Resistance exercise reduces pain and improves function in patients with OA of the knee. Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used by patients with OA to reduce pain and thereby maintain the ability to perform daily activities. However, there is accumulating evidence for a negative effect of NSAIDs, thus many patients with OA are treated with dietary supplementations such as glucosamine and chondroitin sulfate, and some studies show a beneficial effects on cartilage and pain. However, their effect on OA symptoms and cartilage remains controversial. Thus, it is important to investigate whether a potentially beneficial effect of glucosamine and chondroitin sulfate with resistance exercise and manual therapy in patients with knee OA.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTChondroitin SulfateGlucosamine 500 mg Chondroitin sulfate sodium 400mg 3/day
PROCEDUREResistance exercise trainingTreadmill walking 5-10 min for warm up Strength training: (80% of 8RM) Supervised exercise thrice a week and Home Exercise 4 times a week Leg press knee extension Knee flexion Terminal knee extension Mini squats 3 sets 8 reps 10-15 s rep rest interval 1-2 min set rest interval
PROCEDUREManual therapy / Joint MobilizationAnt. tib-fem glide Post tib-fem glide thrice a week Pattelo-femoral joint mobilization
PROCEDURETHE therapyInterferential and Heating for 20 min

Timeline

Start date
2020-01-01
Primary completion
2020-09-01
Completion
2020-11-01
First posted
2020-12-04
Last updated
2020-12-04

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT04654871. Inclusion in this directory is not an endorsement.